| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 69 | 2022 | 200 | 14.070 |
Why?
|
| Bulimia Nervosa | 90 | 2020 | 109 | 13.120 |
Why?
|
| Feeding and Eating Disorders | 99 | 2022 | 182 | 12.900 |
Why?
|
| Bulimia | 116 | 2022 | 142 | 11.180 |
Why?
|
| Obesity, Morbid | 55 | 2021 | 241 | 10.770 |
Why?
|
| Binge-Eating Disorder | 62 | 2020 | 81 | 9.760 |
Why?
|
| Feeding Behavior | 83 | 2021 | 328 | 9.710 |
Why?
|
| Anorexia Nervosa | 95 | 2020 | 142 | 9.100 |
Why?
|
| Weight Loss | 45 | 2021 | 233 | 7.100 |
Why?
|
| Obesity | 51 | 2021 | 973 | 4.680 |
Why?
|
| Gastric Bypass | 23 | 2021 | 113 | 4.300 |
Why?
|
| Affect | 35 | 2019 | 390 | 4.260 |
Why?
|
| Depression | 46 | 2020 | 517 | 3.340 |
Why?
|
| Body Image | 36 | 2020 | 80 | 3.310 |
Why?
|
| Adult | 318 | 2021 | 26916 | 3.100 |
Why?
|
| Surveys and Questionnaires | 93 | 2022 | 2667 | 2.850 |
Why?
|
| Body Mass Index | 67 | 2020 | 775 | 2.830 |
Why?
|
| Female | 350 | 2021 | 46802 | 2.650 |
Why?
|
| Mental Disorders | 19 | 2021 | 418 | 2.410 |
Why?
|
| Humans | 430 | 2023 | 90422 | 2.370 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 42 | 2017 | 220 | 2.260 |
Why?
|
| Compulsive Behavior | 22 | 2017 | 84 | 2.190 |
Why?
|
| Psychotherapy | 16 | 2020 | 73 | 2.050 |
Why?
|
| Hyperphagia | 22 | 2016 | 36 | 2.040 |
Why?
|
| Adolescent | 144 | 2021 | 9336 | 1.950 |
Why?
|
| Personality | 20 | 2019 | 138 | 1.930 |
Why?
|
| Middle Aged | 184 | 2020 | 26295 | 1.930 |
Why?
|
| Young Adult | 98 | 2021 | 6409 | 1.820 |
Why?
|
| Quality of Life | 26 | 2018 | 1687 | 1.790 |
Why?
|
| Male | 176 | 2021 | 42882 | 1.770 |
Why?
|
| Substance-Related Disorders | 18 | 2021 | 422 | 1.750 |
Why?
|
| Impulsive Behavior | 17 | 2021 | 290 | 1.710 |
Why?
|
| Longitudinal Studies | 31 | 2021 | 1085 | 1.700 |
Why?
|
| Psychiatric Status Rating Scales | 49 | 2017 | 497 | 1.570 |
Why?
|
| Eating | 12 | 2018 | 167 | 1.500 |
Why?
|
| Anxiety | 19 | 2020 | 312 | 1.470 |
Why?
|
| Body Weight | 26 | 2017 | 455 | 1.470 |
Why?
|
| Alcoholism | 11 | 2021 | 182 | 1.420 |
Why?
|
| Stress, Psychological | 13 | 2017 | 322 | 1.410 |
Why?
|
| Emotions | 16 | 2021 | 358 | 1.400 |
Why?
|
| Exercise | 14 | 2016 | 328 | 1.360 |
Why?
|
| Gastroplasty | 6 | 2017 | 26 | 1.350 |
Why?
|
| Comorbidity | 43 | 2019 | 955 | 1.340 |
Why?
|
| Antidepressive Agents | 11 | 2014 | 110 | 1.330 |
Why?
|
| Psychotherapy, Group | 13 | 2015 | 34 | 1.290 |
Why?
|
| Vomiting | 22 | 2016 | 196 | 1.260 |
Why?
|
| Postoperative Period | 21 | 2019 | 301 | 1.190 |
Why?
|
| Self Concept | 23 | 2020 | 135 | 1.170 |
Why?
|
| Follow-Up Studies | 46 | 2021 | 3689 | 1.160 |
Why?
|
| Child Abuse | 8 | 2021 | 85 | 1.090 |
Why?
|
| Mood Disorders | 12 | 2017 | 81 | 1.080 |
Why?
|
| Models, Psychological | 15 | 2017 | 159 | 1.050 |
Why?
|
| Hunger | 6 | 2018 | 23 | 1.050 |
Why?
|
| Psychometrics | 19 | 2022 | 331 | 1.040 |
Why?
|
| Cognition | 13 | 2015 | 587 | 0.980 |
Why?
|
| Personality Disorders | 14 | 2016 | 145 | 0.970 |
Why?
|
| Prevalence | 25 | 2018 | 1251 | 0.890 |
Why?
|
| Internal-External Control | 8 | 2016 | 45 | 0.880 |
Why?
|
| Tourette Syndrome | 2 | 2014 | 24 | 0.880 |
Why?
|
| Antipsychotic Agents | 8 | 2020 | 139 | 0.870 |
Why?
|
| Health Behavior | 2 | 2016 | 182 | 0.860 |
Why?
|
| Treatment Outcome | 57 | 2020 | 8362 | 0.820 |
Why?
|
| Cognition Disorders | 9 | 2016 | 236 | 0.810 |
Why?
|
| Motivation | 7 | 2016 | 303 | 0.790 |
Why?
|
| Suicide, Attempted | 9 | 2023 | 136 | 0.770 |
Why?
|
| Telemedicine | 6 | 2020 | 196 | 0.770 |
Why?
|
| Diet | 4 | 2017 | 446 | 0.740 |
Why?
|
| Adaptation, Psychological | 8 | 2017 | 166 | 0.720 |
Why?
|
| Diet, Reducing | 14 | 2017 | 29 | 0.720 |
Why?
|
| Suicidal Ideation | 4 | 2023 | 74 | 0.710 |
Why?
|
| Severity of Illness Index | 24 | 2015 | 1882 | 0.710 |
Why?
|
| Memory | 8 | 2015 | 220 | 0.700 |
Why?
|
| Energy Intake | 13 | 2015 | 98 | 0.700 |
Why?
|
| Encephalitis | 1 | 2020 | 104 | 0.680 |
Why?
|
| Status Epilepticus | 1 | 2020 | 39 | 0.680 |
Why?
|
| Aged | 56 | 2020 | 19371 | 0.670 |
Why?
|
| Self Report | 14 | 2017 | 299 | 0.670 |
Why?
|
| Primary Health Care | 3 | 2010 | 356 | 0.670 |
Why?
|
| Depressive Disorder | 12 | 2014 | 222 | 0.660 |
Why?
|
| Prospective Studies | 24 | 2021 | 4345 | 0.640 |
Why?
|
| Self-Injurious Behavior | 7 | 2017 | 111 | 0.630 |
Why?
|
| Weight Gain | 10 | 2015 | 120 | 0.610 |
Why?
|
| Suicide | 4 | 2013 | 151 | 0.600 |
Why?
|
| Environment | 7 | 2017 | 226 | 0.600 |
Why?
|
| Gastrectomy | 1 | 2018 | 71 | 0.590 |
Why?
|
| Psychotropic Drugs | 5 | 2020 | 79 | 0.590 |
Why?
|
| Borderline Personality Disorder | 6 | 2020 | 36 | 0.580 |
Why?
|
| Personality Inventory | 17 | 2014 | 109 | 0.580 |
Why?
|
| Anti-Obesity Agents | 3 | 2016 | 12 | 0.570 |
Why?
|
| Reward | 1 | 2019 | 196 | 0.570 |
Why?
|
| Seizures | 1 | 2020 | 308 | 0.570 |
Why?
|
| Nutrition Surveys | 2 | 2017 | 111 | 0.570 |
Why?
|
| Manuals as Topic | 2 | 2011 | 9 | 0.570 |
Why?
|
| Interview, Psychological | 14 | 2014 | 69 | 0.560 |
Why?
|
| Dissociative Disorders | 2 | 2017 | 9 | 0.560 |
Why?
|
| Self Care | 4 | 2016 | 166 | 0.550 |
Why?
|
| Running | 3 | 2015 | 26 | 0.550 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 531 | 0.530 |
Why?
|
| Self-Control | 2 | 2016 | 12 | 0.530 |
Why?
|
| Depressive Disorder, Major | 4 | 2023 | 168 | 0.530 |
Why?
|
| Health Status | 9 | 2013 | 370 | 0.520 |
Why?
|
| Mass Screening | 4 | 2017 | 646 | 0.500 |
Why?
|
| Life Change Events | 3 | 2015 | 48 | 0.490 |
Why?
|
| Social Environment | 10 | 2013 | 187 | 0.490 |
Why?
|
| North Dakota | 8 | 2019 | 10 | 0.490 |
Why?
|
| Obsessive-Compulsive Disorder | 6 | 2007 | 160 | 0.490 |
Why?
|
| Combined Modality Therapy | 17 | 2017 | 1708 | 0.470 |
Why?
|
| Patient Satisfaction | 5 | 2011 | 463 | 0.470 |
Why?
|
| Shoes | 1 | 2014 | 5 | 0.460 |
Why?
|
| Tics | 1 | 2014 | 4 | 0.460 |
Why?
|
| Foot Deformities | 1 | 2014 | 7 | 0.460 |
Why?
|
| Time Factors | 18 | 2021 | 5361 | 0.460 |
Why?
|
| Neuropsychological Tests | 13 | 2016 | 513 | 0.460 |
Why?
|
| Dermatologic Surgical Procedures | 2 | 2011 | 16 | 0.460 |
Why?
|
| Reproducibility of Results | 23 | 2022 | 2781 | 0.450 |
Why?
|
| Fluoxetine | 5 | 2013 | 41 | 0.450 |
Why?
|
| Energy Metabolism | 3 | 2002 | 283 | 0.450 |
Why?
|
| Body Dysmorphic Disorders | 2 | 2016 | 12 | 0.450 |
Why?
|
| Anxiety Disorders | 10 | 2013 | 152 | 0.440 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 124 | 0.440 |
Why?
|
| Personal Satisfaction | 4 | 2016 | 64 | 0.440 |
Why?
|
| Interviews as Topic | 5 | 2011 | 344 | 0.430 |
Why?
|
| Epilepsy | 2 | 2020 | 424 | 0.430 |
Why?
|
| Risk Factors | 27 | 2023 | 5576 | 0.430 |
Why?
|
| Handwriting | 1 | 2013 | 6 | 0.420 |
Why?
|
| Motor Skills Disorders | 1 | 2013 | 14 | 0.420 |
Why?
|
| Executive Function | 10 | 2015 | 96 | 0.420 |
Why?
|
| Temperament | 5 | 2014 | 28 | 0.410 |
Why?
|
| Health Services | 2 | 2010 | 56 | 0.410 |
Why?
|
| Circadian Rhythm | 4 | 2010 | 304 | 0.410 |
Why?
|
| Cathartics | 5 | 2007 | 27 | 0.410 |
Why?
|
| Child Abuse, Sexual | 6 | 2011 | 19 | 0.410 |
Why?
|
| Women | 2 | 2011 | 25 | 0.400 |
Why?
|
| Diagnosis, Differential | 13 | 2020 | 1607 | 0.390 |
Why?
|
| Preoperative Period | 6 | 2014 | 94 | 0.390 |
Why?
|
| Ethanol | 2 | 2021 | 257 | 0.390 |
Why?
|
| Mental Health Services | 2 | 2004 | 59 | 0.380 |
Why?
|
| Calcium Fluoride | 1 | 2011 | 1 | 0.380 |
Why?
|
| Dental Caries | 1 | 2011 | 4 | 0.380 |
Why?
|
| Models, Statistical | 6 | 2013 | 575 | 0.380 |
Why?
|
| Appetite Depressants | 4 | 2015 | 11 | 0.380 |
Why?
|
| Regression Analysis | 11 | 2015 | 590 | 0.380 |
Why?
|
| Mental Health | 1 | 2013 | 181 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2016 | 844 | 0.370 |
Why?
|
| Self-Assessment | 3 | 2015 | 47 | 0.370 |
Why?
|
| Anorexia | 2 | 2012 | 28 | 0.370 |
Why?
|
| Cohort Studies | 10 | 2021 | 2893 | 0.360 |
Why?
|
| United States | 21 | 2021 | 7135 | 0.360 |
Why?
|
| Cross-Sectional Studies | 11 | 2020 | 1734 | 0.350 |
Why?
|
| Ecological Momentary Assessment | 4 | 2017 | 33 | 0.350 |
Why?
|
| Internet | 3 | 2011 | 324 | 0.350 |
Why?
|
| Postoperative Complications | 6 | 2019 | 2336 | 0.350 |
Why?
|
| Postoperative Care | 5 | 2017 | 234 | 0.340 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2014 | 50 | 0.340 |
Why?
|
| Nanoparticles | 1 | 2011 | 165 | 0.340 |
Why?
|
| Health Surveys | 6 | 2014 | 239 | 0.330 |
Why?
|
| Research Design | 5 | 2007 | 590 | 0.320 |
Why?
|
| Self-Help Groups | 3 | 2020 | 14 | 0.310 |
Why?
|
| Age Factors | 12 | 2015 | 1869 | 0.310 |
Why?
|
| Health Care Costs | 2 | 2009 | 237 | 0.300 |
Why?
|
| Linear Models | 6 | 2014 | 422 | 0.300 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 1692 | 0.300 |
Why?
|
| Minnesota | 6 | 2013 | 45 | 0.300 |
Why?
|
| Personality Assessment | 12 | 2011 | 97 | 0.300 |
Why?
|
| Cyclobutanes | 2 | 2007 | 7 | 0.290 |
Why?
|
| Imipramine | 4 | 2002 | 16 | 0.290 |
Why?
|
| Child | 21 | 2021 | 7211 | 0.290 |
Why?
|
| Motor Activity | 3 | 2015 | 326 | 0.290 |
Why?
|
| Analysis of Variance | 11 | 2016 | 898 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2023 | 2362 | 0.280 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 136 | 0.280 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2011 | 19 | 0.280 |
Why?
|
| Professional-Patient Relations | 3 | 2017 | 54 | 0.280 |
Why?
|
| Phenotype | 11 | 2019 | 2462 | 0.280 |
Why?
|
| Trichotillomania | 3 | 2011 | 94 | 0.280 |
Why?
|
| Affective Symptoms | 4 | 2014 | 51 | 0.270 |
Why?
|
| Prognosis | 14 | 2019 | 3805 | 0.270 |
Why?
|
| Thinness | 3 | 2012 | 46 | 0.270 |
Why?
|
| Satiety Response | 3 | 2005 | 4 | 0.260 |
Why?
|
| Attention | 9 | 2015 | 396 | 0.260 |
Why?
|
| Escape Reaction | 1 | 2006 | 12 | 0.260 |
Why?
|
| Pain Threshold | 3 | 2012 | 61 | 0.260 |
Why?
|
| Snacks | 2 | 2016 | 4 | 0.260 |
Why?
|
| Factor Analysis, Statistical | 8 | 2016 | 114 | 0.250 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2015 | 13 | 0.250 |
Why?
|
| Empirical Research | 3 | 2014 | 19 | 0.250 |
Why?
|
| Interpersonal Relations | 5 | 2016 | 178 | 0.240 |
Why?
|
| Adolescent Behavior | 3 | 2021 | 109 | 0.240 |
Why?
|
| Obsessive Behavior | 3 | 2015 | 8 | 0.240 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 391 | 0.240 |
Why?
|
| Patient Dropouts | 4 | 2011 | 30 | 0.240 |
Why?
|
| Smoking | 2 | 2021 | 627 | 0.240 |
Why?
|
| Computers | 1 | 2004 | 111 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1054 | 0.230 |
Why?
|
| Schizophrenia | 1 | 2008 | 496 | 0.230 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 7 | 2010 | 284 | 0.230 |
Why?
|
| Behavior Therapy | 4 | 2018 | 89 | 0.220 |
Why?
|
| Sexual Behavior | 3 | 2008 | 316 | 0.220 |
Why?
|
| Laxatives | 2 | 2017 | 13 | 0.220 |
Why?
|
| Lactones | 2 | 2016 | 26 | 0.220 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2014 | 69 | 0.220 |
Why?
|
| Incidence | 10 | 2017 | 1593 | 0.220 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2014 | 36 | 0.210 |
Why?
|
| Exercise Therapy | 2 | 2016 | 86 | 0.210 |
Why?
|
| User-Computer Interface | 1 | 2004 | 187 | 0.210 |
Why?
|
| Sex Factors | 6 | 2013 | 1074 | 0.210 |
Why?
|
| Psychological Tests | 4 | 2013 | 91 | 0.210 |
Why?
|
| Patient Selection | 5 | 2014 | 682 | 0.210 |
Why?
|
| Socioeconomic Factors | 4 | 2018 | 593 | 0.200 |
Why?
|
| Body Size | 2 | 2013 | 93 | 0.200 |
Why?
|
| Psychopathology | 3 | 2016 | 30 | 0.200 |
Why?
|
| Electroencephalography | 2 | 2020 | 758 | 0.200 |
Why?
|
| Rape | 4 | 2003 | 17 | 0.200 |
Why?
|
| Menstrual Cycle | 1 | 2002 | 58 | 0.200 |
Why?
|
| Genetic Variation | 3 | 2014 | 1381 | 0.200 |
Why?
|
| Patient Compliance | 4 | 2017 | 230 | 0.190 |
Why?
|
| Social Adjustment | 4 | 2011 | 47 | 0.190 |
Why?
|
| Fertility | 1 | 2002 | 116 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2014 | 222 | 0.190 |
Why?
|
| Preoperative Care | 4 | 2017 | 400 | 0.190 |
Why?
|
| Meals | 3 | 2016 | 22 | 0.190 |
Why?
|
| Computers, Handheld | 3 | 2012 | 33 | 0.190 |
Why?
|
| Psychological Trauma | 1 | 2021 | 8 | 0.190 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2012 | 116 | 0.180 |
Why?
|
| Ghrelin | 2 | 2013 | 29 | 0.180 |
Why?
|
| Age of Onset | 7 | 2015 | 319 | 0.180 |
Why?
|
| Violence | 2 | 2010 | 155 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 28 | 0.180 |
Why?
|
| England | 1 | 2020 | 38 | 0.180 |
Why?
|
| Hashimoto Disease | 1 | 2020 | 11 | 0.180 |
Why?
|
| Midwestern United States | 3 | 2016 | 83 | 0.180 |
Why?
|
| Leptin | 2 | 2014 | 102 | 0.180 |
Why?
|
| Retrospective Studies | 11 | 2020 | 9307 | 0.180 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 360 | 0.170 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 275 | 0.170 |
Why?
|
| Risk-Taking | 4 | 2016 | 157 | 0.170 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 615 | 0.170 |
Why?
|
| Benzodiazepines | 3 | 2008 | 69 | 0.160 |
Why?
|
| ROC Curve | 3 | 2013 | 780 | 0.160 |
Why?
|
| Double-Blind Method | 9 | 2015 | 1722 | 0.160 |
Why?
|
| Neurology | 1 | 2020 | 75 | 0.160 |
Why?
|
| Diuretics | 3 | 2009 | 76 | 0.160 |
Why?
|
| Logistic Models | 9 | 2011 | 1216 | 0.160 |
Why?
|
| Amenorrhea | 2 | 2013 | 28 | 0.160 |
Why?
|
| Lisdexamfetamine Dimesylate | 2 | 2015 | 2 | 0.160 |
Why?
|
| Commerce | 3 | 2008 | 31 | 0.160 |
Why?
|
| Conduct Disorder | 1 | 1999 | 64 | 0.160 |
Why?
|
| Veterans Health | 1 | 2018 | 16 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 52 | 0.160 |
Why?
|
| Anger | 2 | 2012 | 81 | 0.160 |
Why?
|
| Alcohol-Related Disorders | 2 | 2012 | 18 | 0.160 |
Why?
|
| Bias | 2 | 2007 | 135 | 0.160 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 180 | 0.150 |
Why?
|
| Case-Control Studies | 7 | 2021 | 1872 | 0.150 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 29 | 0.150 |
Why?
|
| Regenerative Medicine | 1 | 2018 | 26 | 0.150 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2018 | 57 | 0.150 |
Why?
|
| Electrolytes | 2 | 1997 | 52 | 0.150 |
Why?
|
| Psychology | 2 | 2015 | 25 | 0.150 |
Why?
|
| Periodicity | 2 | 2009 | 119 | 0.150 |
Why?
|
| Food Deprivation | 2 | 2015 | 24 | 0.150 |
Why?
|
| Emotional Adjustment | 1 | 2017 | 2 | 0.150 |
Why?
|
| Pneumothorax | 1 | 1998 | 53 | 0.150 |
Why?
|
| Portugal | 1 | 2017 | 26 | 0.150 |
Why?
|
| Pregnancy | 5 | 2020 | 3063 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2023 | 2421 | 0.140 |
Why?
|
| Hospitals | 1 | 2020 | 308 | 0.140 |
Why?
|
| Negotiating | 1 | 2017 | 20 | 0.140 |
Why?
|
| Risperidone | 2 | 2008 | 23 | 0.140 |
Why?
|
| Pilot Projects | 4 | 2015 | 878 | 0.140 |
Why?
|
| Parents | 3 | 2008 | 289 | 0.130 |
Why?
|
| Perfectionism | 1 | 2016 | 1 | 0.130 |
Why?
|
| Drug Therapy | 2 | 2006 | 69 | 0.130 |
Why?
|
| Attitude to Health | 2 | 2016 | 220 | 0.130 |
Why?
|
| Symptom Assessment | 2 | 2013 | 68 | 0.130 |
Why?
|
| Fructose | 1 | 2016 | 36 | 0.130 |
Why?
|
| Clinical Protocols | 2 | 2011 | 158 | 0.130 |
Why?
|
| Memory Disorders | 2 | 2013 | 69 | 0.130 |
Why?
|
| Wakefulness | 2 | 2007 | 136 | 0.130 |
Why?
|
| Medicare | 1 | 2019 | 428 | 0.130 |
Why?
|
| Alcoholic Intoxication | 1 | 2016 | 37 | 0.130 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 47 | 0.130 |
Why?
|
| Aggression | 1 | 1999 | 323 | 0.130 |
Why?
|
| Data Collection | 3 | 2006 | 377 | 0.130 |
Why?
|
| Theft | 2 | 2010 | 12 | 0.130 |
Why?
|
| Emotional Intelligence | 1 | 2015 | 22 | 0.120 |
Why?
|
| Social Identification | 1 | 2015 | 28 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 431 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 321 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 307 | 0.120 |
Why?
|
| Nutritional Status | 1 | 2015 | 81 | 0.120 |
Why?
|
| Malnutrition | 1 | 2015 | 33 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2017 | 2334 | 0.120 |
Why?
|
| Warfarin | 1 | 2015 | 104 | 0.120 |
Why?
|
| Intention to Treat Analysis | 2 | 2013 | 72 | 0.120 |
Why?
|
| Publishing | 2 | 2006 | 91 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2015 | 109 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2015 | 44 | 0.120 |
Why?
|
| Sexuality | 1 | 2014 | 41 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 258 | 0.120 |
Why?
|
| Complementary Therapies | 2 | 2006 | 55 | 0.120 |
Why?
|
| Cystatin C | 1 | 2014 | 27 | 0.120 |
Why?
|
| Melanocortins | 1 | 2014 | 4 | 0.120 |
Why?
|
| Alkaline Phosphatase | 1 | 2014 | 132 | 0.120 |
Why?
|
| Diet Records | 2 | 2011 | 19 | 0.110 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 63 | 0.110 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2013 | 1 | 0.110 |
Why?
|
| Femininity | 1 | 2013 | 3 | 0.110 |
Why?
|
| Health Status Indicators | 2 | 2006 | 103 | 0.110 |
Why?
|
| Fasting | 1 | 2014 | 166 | 0.110 |
Why?
|
| Epoxide Hydrolases | 1 | 2013 | 7 | 0.110 |
Why?
|
| Physical Endurance | 1 | 2013 | 10 | 0.110 |
Why?
|
| Dextroamphetamine | 1 | 2015 | 108 | 0.110 |
Why?
|
| Self Disclosure | 2 | 2009 | 32 | 0.110 |
Why?
|
| Masculinity | 1 | 2013 | 16 | 0.110 |
Why?
|
| Cues | 1 | 1995 | 175 | 0.110 |
Why?
|
| Genomics | 1 | 2019 | 780 | 0.110 |
Why?
|
| Cause of Death | 2 | 2009 | 270 | 0.110 |
Why?
|
| Athletes | 1 | 2013 | 52 | 0.110 |
Why?
|
| Overweight | 2 | 2011 | 118 | 0.110 |
Why?
|
| Thiophenes | 1 | 2013 | 44 | 0.110 |
Why?
|
| Psychopharmacology | 1 | 2013 | 26 | 0.110 |
Why?
|
| Pellagra | 1 | 2013 | 2 | 0.110 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2013 | 48 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2012 | 27 | 0.110 |
Why?
|
| Perceptual Disorders | 1 | 2012 | 12 | 0.110 |
Why?
|
| Ecology | 1 | 2013 | 76 | 0.100 |
Why?
|
| Pain Perception | 1 | 2012 | 18 | 0.100 |
Why?
|
| Mothers | 2 | 2011 | 145 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2020 | 349 | 0.100 |
Why?
|
| Appetite Regulation | 1 | 2012 | 9 | 0.100 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 125 | 0.100 |
Why?
|
| Cluster Analysis | 3 | 2010 | 372 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2013 | 76 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 451 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2013 | 107 | 0.100 |
Why?
|
| Laparoscopy | 2 | 2016 | 781 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2015 | 439 | 0.100 |
Why?
|
| Counseling | 2 | 2015 | 167 | 0.100 |
Why?
|
| Genotype | 3 | 2011 | 1855 | 0.100 |
Why?
|
| Predictive Value of Tests | 8 | 2013 | 1741 | 0.100 |
Why?
|
| Community Mental Health Services | 2 | 2008 | 17 | 0.100 |
Why?
|
| Calcium Hydroxide | 1 | 2011 | 1 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2011 | 14 | 0.100 |
Why?
|
| Fluorides | 1 | 2011 | 13 | 0.100 |
Why?
|
| Ammonium Compounds | 1 | 2011 | 9 | 0.100 |
Why?
|
| Methods | 1 | 2011 | 151 | 0.090 |
Why?
|
| Focus Groups | 1 | 2012 | 178 | 0.090 |
Why?
|
| Aging | 2 | 2014 | 727 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 81 | 0.090 |
Why?
|
| Mental Recall | 4 | 2015 | 163 | 0.090 |
Why?
|
| Medical History Taking | 2 | 2015 | 83 | 0.090 |
Why?
|
| Sertraline | 1 | 2010 | 7 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2015 | 846 | 0.090 |
Why?
|
| Particle Size | 1 | 2011 | 127 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 6802 | 0.090 |
Why?
|
| Reference Values | 4 | 2010 | 662 | 0.090 |
Why?
|
| Disease Progression | 2 | 2013 | 1483 | 0.090 |
Why?
|
| Habits | 1 | 2010 | 18 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2691 | 0.090 |
Why?
|
| Germany | 4 | 2010 | 74 | 0.090 |
Why?
|
| Starvation | 1 | 2010 | 23 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 2008 | 80 | 0.090 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 3 | 0.080 |
Why?
|
| Aspartame | 1 | 2009 | 5 | 0.080 |
Why?
|
| Drinking | 1 | 2009 | 33 | 0.080 |
Why?
|
| Sweetening Agents | 1 | 2009 | 17 | 0.080 |
Why?
|
| Random Allocation | 3 | 2002 | 327 | 0.080 |
Why?
|
| Utilization Review | 1 | 2009 | 23 | 0.080 |
Why?
|
| Reproduction | 1 | 2011 | 199 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 988 | 0.080 |
Why?
|
| Hoarding Disorder | 1 | 2009 | 7 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 198 | 0.080 |
Why?
|
| Negativism | 1 | 2008 | 2 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 219 | 0.080 |
Why?
|
| Integrative Medicine | 1 | 2008 | 10 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 416 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 4 | 2013 | 303 | 0.080 |
Why?
|
| Benzhydryl Compounds | 1 | 2008 | 44 | 0.080 |
Why?
|
| Caffeine | 1 | 2009 | 84 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 294 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2011 | 458 | 0.080 |
Why?
|
| Mortality | 1 | 2009 | 148 | 0.080 |
Why?
|
| Perinatology | 1 | 2008 | 14 | 0.080 |
Why?
|
| Health Expenditures | 1 | 2009 | 90 | 0.080 |
Why?
|
| Hospitalization | 1 | 2014 | 898 | 0.080 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2008 | 25 | 0.070 |
Why?
|
| Statistics as Topic | 4 | 2013 | 234 | 0.070 |
Why?
|
| Child of Impaired Parents | 1 | 2008 | 19 | 0.070 |
Why?
|
| Surgery, Plastic | 1 | 2008 | 42 | 0.070 |
Why?
|
| Validation Studies as Topic | 1 | 2007 | 17 | 0.070 |
Why?
|
| International Cooperation | 1 | 2008 | 126 | 0.070 |
Why?
|
| Reaction Time | 3 | 2015 | 311 | 0.070 |
Why?
|
| Genetic Linkage | 2 | 2008 | 624 | 0.070 |
Why?
|
| Hypertension | 1 | 2013 | 746 | 0.070 |
Why?
|
| Odds Ratio | 3 | 2012 | 679 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2012 | 281 | 0.070 |
Why?
|
| Ipecac | 1 | 2007 | 2 | 0.070 |
Why?
|
| Emetics | 1 | 2007 | 4 | 0.070 |
Why?
|
| Recurrence | 4 | 2009 | 1162 | 0.070 |
Why?
|
| Plants, Medicinal | 1 | 2006 | 40 | 0.070 |
Why?
|
| Postpartum Period | 1 | 2008 | 153 | 0.070 |
Why?
|
| Guilt | 2 | 2016 | 11 | 0.070 |
Why?
|
| Nutrition Disorders | 1 | 2006 | 15 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2011 | 561 | 0.070 |
Why?
|
| Somnambulism | 1 | 2006 | 1 | 0.070 |
Why?
|
| Endocrine System Diseases | 1 | 2006 | 23 | 0.070 |
Why?
|
| Stomach | 2 | 1997 | 111 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2014 | 1671 | 0.070 |
Why?
|
| Australian Capital Territory | 1 | 2006 | 1 | 0.070 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2006 | 17 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2006 | 58 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 220 | 0.060 |
Why?
|
| Defense Mechanisms | 1 | 2005 | 5 | 0.060 |
Why?
|
| Area Under Curve | 3 | 2013 | 338 | 0.060 |
Why?
|
| Fear | 2 | 2016 | 80 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1284 | 0.060 |
Why?
|
| Drugs, Investigational | 1 | 2006 | 38 | 0.060 |
Why?
|
| Patient Education as Topic | 3 | 2013 | 364 | 0.060 |
Why?
|
| Compulsive Personality Disorder | 1 | 2005 | 16 | 0.060 |
Why?
|
| Menarche | 3 | 2011 | 30 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2001 | 651 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 788 | 0.060 |
Why?
|
| Phytotherapy | 1 | 2006 | 136 | 0.060 |
Why?
|
| Placebos | 4 | 2007 | 211 | 0.060 |
Why?
|
| Verbal Behavior | 2 | 2016 | 32 | 0.060 |
Why?
|
| Travel | 1 | 2005 | 73 | 0.060 |
Why?
|
| Attitude | 1 | 2006 | 130 | 0.060 |
Why?
|
| Serotonin Antagonists | 1 | 2005 | 35 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1196 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2005 | 124 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 151 | 0.060 |
Why?
|
| Sleep Wake Disorders | 1 | 2006 | 118 | 0.060 |
Why?
|
| Amitriptyline | 1 | 1984 | 11 | 0.060 |
Why?
|
| Somatoform Disorders | 1 | 2004 | 29 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2006 | 174 | 0.060 |
Why?
|
| Food | 2 | 2001 | 89 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2005 | 188 | 0.060 |
Why?
|
| Child Development | 1 | 1986 | 167 | 0.060 |
Why?
|
| Education | 1 | 2004 | 58 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 982 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2006 | 276 | 0.060 |
Why?
|
| Automobile Driving | 1 | 2004 | 31 | 0.060 |
Why?
|
| Verbal Learning | 2 | 2014 | 30 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 1 | 2003 | 23 | 0.060 |
Why?
|
| Lithium | 1 | 2003 | 62 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 178 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2020 | 959 | 0.050 |
Why?
|
| Europe | 2 | 2011 | 328 | 0.050 |
Why?
|
| Zinc | 1 | 2003 | 95 | 0.050 |
Why?
|
| Gravidity | 1 | 2002 | 7 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 223 | 0.050 |
Why?
|
| Health Promotion | 1 | 2004 | 164 | 0.050 |
Why?
|
| Personality Tests | 2 | 2014 | 21 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2002 | 21 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2003 | 387 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2023 | 253 | 0.050 |
Why?
|
| Risk | 2 | 1999 | 656 | 0.050 |
Why?
|
| Truth Disclosure | 1 | 2002 | 92 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2002 | 285 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 438 | 0.050 |
Why?
|
| Narcissism | 1 | 2001 | 3 | 0.050 |
Why?
|
| Infertility, Female | 1 | 2002 | 96 | 0.050 |
Why?
|
| Juvenile Delinquency | 1 | 2001 | 26 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 343 | 0.050 |
Why?
|
| Child Welfare | 1 | 2001 | 39 | 0.050 |
Why?
|
| Chlorides | 1 | 2001 | 104 | 0.050 |
Why?
|
| Tooth Erosion | 2 | 1991 | 3 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2001 | 152 | 0.050 |
Why?
|
| Prejudice | 1 | 2001 | 48 | 0.050 |
Why?
|
| Outpatients | 1 | 2001 | 103 | 0.040 |
Why?
|
| Body Temperature Regulation | 2 | 1995 | 56 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1929 | 0.040 |
Why?
|
| Sodium | 1 | 2001 | 334 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2002 | 260 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3484 | 0.040 |
Why?
|
| Software | 1 | 2004 | 669 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2021 | 67 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 1993 | 1141 | 0.040 |
Why?
|
| Rural Population | 1 | 2001 | 147 | 0.040 |
Why?
|
| Research Personnel | 1 | 2000 | 72 | 0.040 |
Why?
|
| Infant | 3 | 2013 | 3183 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 721 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2000 | 118 | 0.040 |
Why?
|
| Urban Population | 1 | 2001 | 225 | 0.040 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1999 | 22 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2020 | 126 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 116 | 0.040 |
Why?
|
| Students | 1 | 2001 | 171 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1915 | 0.040 |
Why?
|
| Fluvoxamine | 1 | 1998 | 7 | 0.040 |
Why?
|
| Demography | 1 | 1999 | 183 | 0.040 |
Why?
|
| Educational Status | 3 | 2011 | 194 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 399 | 0.040 |
Why?
|
| Kansas | 1 | 2018 | 6 | 0.040 |
Why?
|
| Physician's Role | 1 | 2000 | 176 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1980 | 201 | 0.040 |
Why?
|
| Population Surveillance | 1 | 1999 | 209 | 0.040 |
Why?
|
| Medical Records | 2 | 2011 | 120 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 471 | 0.040 |
Why?
|
| Perception | 1 | 1999 | 181 | 0.040 |
Why?
|
| Veterans | 1 | 2018 | 86 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 2019 | 0.040 |
Why?
|
| Personality Development | 3 | 2001 | 23 | 0.040 |
Why?
|
| Object Attachment | 1 | 2017 | 19 | 0.040 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 1997 | 3 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 271 | 0.040 |
Why?
|
| Gastric Dilatation | 1 | 1997 | 3 | 0.040 |
Why?
|
| Individuality | 1 | 1998 | 110 | 0.040 |
Why?
|
| Epidemiologic Factors | 1 | 1996 | 5 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2013 | 3764 | 0.030 |
Why?
|
| Canada | 1 | 1996 | 201 | 0.030 |
Why?
|
| Research | 1 | 2017 | 252 | 0.030 |
Why?
|
| Hostility | 1 | 2016 | 25 | 0.030 |
Why?
|
| Mass Media | 1 | 2015 | 27 | 0.030 |
Why?
|
| Potassium | 1 | 1997 | 258 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2015 | 39 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2015 | 17 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2015 | 20 | 0.030 |
Why?
|
| Nutrition Policy | 1 | 2015 | 13 | 0.030 |
Why?
|
| Micronutrients | 1 | 2015 | 18 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 1995 | 49 | 0.030 |
Why?
|
| Biomarkers | 1 | 2001 | 1795 | 0.030 |
Why?
|
| Nociceptors | 1 | 1994 | 30 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptor, trkB | 1 | 2014 | 3 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 195 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 788 | 0.030 |
Why?
|
| Lithium Carbonate | 1 | 1993 | 7 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2013 | 25 | 0.030 |
Why?
|
| Psychotherapy, Brief | 1 | 1993 | 12 | 0.030 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2013 | 2 | 0.030 |
Why?
|
| Brain | 1 | 2004 | 2315 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 69 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2013 | 120 | 0.030 |
Why?
|
| Half-Life | 1 | 2013 | 97 | 0.030 |
Why?
|
| Physicians | 1 | 2001 | 691 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2013 | 170 | 0.030 |
Why?
|
| Motivational Interviewing | 1 | 2013 | 22 | 0.030 |
Why?
|
| Social Behavior | 1 | 2016 | 299 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 48 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2014 | 212 | 0.030 |
Why?
|
| Pain Measurement | 1 | 1994 | 334 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 528 | 0.030 |
Why?
|
| Social Class | 1 | 2013 | 136 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 1995 | 263 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 306 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2012 | 12 | 0.030 |
Why?
|
| Naltrexone | 1 | 1993 | 138 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 306 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 305 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 432 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 671 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 46 | 0.020 |
Why?
|
| Drive | 1 | 2011 | 3 | 0.020 |
Why?
|
| Colic | 1 | 2011 | 7 | 0.020 |
Why?
|
| Arousal | 1 | 1992 | 170 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 161 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2011 | 32 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 57 | 0.020 |
Why?
|
| Cholesterol | 1 | 2013 | 361 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 156 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 315 | 0.020 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2011 | 44 | 0.020 |
Why?
|
| Walking | 1 | 2011 | 93 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 198 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 195 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 103 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 167 | 0.020 |
Why?
|
| North America | 1 | 2011 | 186 | 0.020 |
Why?
|
| Community Health Planning | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 34 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2011 | 105 | 0.020 |
Why?
|
| Language | 1 | 2011 | 157 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1152 | 0.020 |
Why?
|
| Selection Bias | 1 | 1989 | 36 | 0.020 |
Why?
|
| Desipramine | 1 | 1989 | 9 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1989 | 7 | 0.020 |
Why?
|
| Nortriptyline | 1 | 1989 | 6 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 497 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2010 | 54 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 186 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 289 | 0.020 |
Why?
|
| DNA Damage | 1 | 2011 | 374 | 0.020 |
Why?
|
| Awareness | 1 | 2010 | 88 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2009 | 63 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 284 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2009 | 20 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 399 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1131 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 317 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2008 | 93 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2009 | 189 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 638 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2009 | 149 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 2010 | 135 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2008 | 58 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 875 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1493 | 0.020 |
Why?
|
| Self Medication | 1 | 2007 | 6 | 0.020 |
Why?
|
| Self Administration | 1 | 2007 | 72 | 0.020 |
Why?
|
| Time | 1 | 2007 | 77 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 854 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1159 | 0.020 |
Why?
|
| Women's Health | 1 | 2007 | 103 | 0.020 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1986 | 19 | 0.020 |
Why?
|
| Family | 1 | 1988 | 324 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 1246 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 2005 | 37 | 0.020 |
Why?
|
| Receptors, Serotonin | 1 | 2005 | 34 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 262 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 3261 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 102 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 95 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1983 | 34 | 0.010 |
Why?
|
| Work | 1 | 2003 | 15 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1983 | 33 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1983 | 80 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 1983 | 25 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1983 | 116 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 791 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1983 | 141 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2004 | 162 | 0.010 |
Why?
|
| Hormones | 1 | 1983 | 139 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 66 | 0.010 |
Why?
|
| Serotonin | 1 | 2004 | 221 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 244 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2003 | 66 | 0.010 |
Why?
|
| Food, Formulated | 1 | 2002 | 24 | 0.010 |
Why?
|
| Mandatory Reporting | 1 | 2001 | 7 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2001 | 48 | 0.010 |
Why?
|
| Social Control, Formal | 1 | 2001 | 12 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 452 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1986 | 2501 | 0.010 |
Why?
|
| Probability | 1 | 2000 | 355 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2001 | 502 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1997 | 73 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 11898 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1980 | 498 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1997 | 43 | 0.010 |
Why?
|
| Observer Variation | 1 | 1993 | 615 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 27606 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1993 | 1499 | 0.010 |
Why?
|